Literature DB >> 8133470

Voltaren associated with medication keratitis.

J P Gills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8133470     DOI： 10.1016/s0886-3350(13)80063-6

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN： 0886-3350            Impact factor:   3.351


× No keyword cloud information.
  7 in total

1.  Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2001

Review 2.  Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.

Authors:  Bruce I Gaynes; Richard Fiscella
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

Review 4.  The role of NSAIDs in the management of postoperative ophthalmic inflammation.

Authors:  Joseph Colin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.

Authors:  Keping Xu; Mark McDermott; Linda Villanueva; Rhett M Schiffman; David A Hollander
Journal:  Clin Ophthalmol       Date:  2011-02-28

6.  Bilateral corneal melting associated with topical diclofenac 0.1% after cataract surgery in a patient with Sjögren's syndrome.

Authors:  Pei-Ning Tu; Yu-Chih Hou
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

7.  Unique circumferential peripheral keratitis in relapsing polychondritis: A case report.

Authors:  Naohiro Motozawa; Takahiro Nakamura; Seiji Takagi; Masashi Fujihara; Yasuhiko Hirami; Kazuhiro Ishida; Chie Sotozono; Yasuo Kurimoto
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.